These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 17397015)

  • 1. On recombinant human erythropoietin preventing the death of mice during cerebral malaria.
    Lackner P; Helbok R; Schmutzhard E
    J Infect Dis; 2007 May; 195(9):1391; author reply 1391-2. PubMed ID: 17397015
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human erythropoietin prevents the death of mice during cerebral malaria.
    Kaiser K; Texier A; Ferrandiz J; Buguet A; Meiller A; Latour C; Peyron F; Cespuglio R; Picot S
    J Infect Dis; 2006 Apr; 193(7):987-95. PubMed ID: 16518761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria.
    Wiese L; Hempel C; Penkowa M; Kirkby N; Kurtzhals JA
    Malar J; 2008 Jan; 7():3. PubMed ID: 18179698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
    Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
    Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium berghei ANKA: erythropoietin activates neural stem cells in an experimental cerebral malaria model.
    Core A; Hempel C; Kurtzhals JA; Penkowa M
    Exp Parasitol; 2011 Feb; 127(2):500-5. PubMed ID: 21044627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin.
    Hempel C; Combes V; Hunt NH; Kurtzhals JA; Grau GE
    Am J Pathol; 2011 Oct; 179(4):1939-50. PubMed ID: 21854739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages.
    Lackner P; Burger C; Pfaller K; Heussler V; Helbok R; Morandell M; Broessner G; Tannich E; Schmutzhard E; Beer R
    Neuropathol Appl Neurobiol; 2007 Oct; 33(5):560-71. PubMed ID: 17442059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria.
    Lackner P; Hametner C; Beer R; Burger C; Broessner G; Helbok R; Speth C; Schmutzhard E
    Malar J; 2008 Oct; 7():207. PubMed ID: 18847493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral malaria: human versus mouse studies.
    Stevenson MM; Gros P; Olivier M; Fortin A; Serghides L
    Trends Parasitol; 2010 Jun; 26(6):274-5. PubMed ID: 20382077
    [No Abstract]   [Full Text] [Related]  

  • 10. Murine cerebral malaria: the whole story.
    Hunt NH; Grau GE; Engwerda C; Barnum SR; van der Heyde H; Hansen DS; Schofield L; Golenser J
    Trends Parasitol; 2010 Jun; 26(6):272-4. PubMed ID: 20382078
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebral malaria: in praise of epistemes.
    Rénia L; Grüner AC; Snounou G
    Trends Parasitol; 2010 Jun; 26(6):275-7. PubMed ID: 20363672
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral malaria: protection by erythropoietin.
    Bienvenu AL; Picot S
    Methods Mol Biol; 2013; 982():315-24. PubMed ID: 23456877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review Article: blood-brain barrier in falciparum malaria.
    Gitau EN; Newton CR
    Trop Med Int Health; 2005 Mar; 10(3):285-92. PubMed ID: 15730513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural and histopathological alterations in mice with cerebral malaria.
    Lackner P; Beer R; Heussler V; Goebel G; Rudzki D; Helbok R; Tannich E; Schmutzhard E
    Neuropathol Appl Neurobiol; 2006 Apr; 32(2):177-88. PubMed ID: 16599946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A histologic study of brain in fatal cerebral malaria].
    Burel-Vandenbos F; Effa'a C; Alunni V; Cardot-Leccia N; Haudebourg J; Michiels JF
    Ann Pathol; 2008 Dec; 28(6):495-7. PubMed ID: 19084718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on drug metabolizing enzymes during arteether treatment of Plasmodium yoelii nigeriensis infected mice cerebral microvessels.
    Agrawal A
    J Commun Dis; 2005 Mar; 37(1):44-50. PubMed ID: 16637400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Nod-like receptors alters inflammatory response to infection but does not confer protection in experimental cerebral malaria.
    Finney CA; Lu Z; LeBourhis L; Philpott DJ; Kain KC
    Am J Trop Med Hyg; 2009 May; 80(5):718-22. PubMed ID: 19407112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited role of CD4+Foxp3+ regulatory T cells in the control of experimental cerebral malaria.
    Steeg C; Adler G; Sparwasser T; Fleischer B; Jacobs T
    J Immunol; 2009 Dec; 183(11):7014-22. PubMed ID: 19890049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria.
    Hempel C; Hyttel P; Staalsø T; Nyengaard JR; Kurtzhals JA
    Malar J; 2012 Jun; 11():216. PubMed ID: 22741599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered nucleotide receptor expression in a murine model of cerebral malaria.
    Marín-García P; Sánchez-Nogueiro J; Diez A; León-Otegui M; Linares M; García-Palencia P; Bautista JM; Miras-Portugal MT
    J Infect Dis; 2009 Oct; 200(8):1279-88. PubMed ID: 19758097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.